CME Group Inc. (NASDAQ:CME) Given Consensus Recommendation of “Hold” by Analysts

Shares of CME Group Inc. (NASDAQ:CME) have earned a consensus rating of “Hold” from the fifteen ratings firms that are currently covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $222.73.

Several research analysts have recently weighed in on the stock. Piper Sandler lifted their price target on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Bank of America lifted their target price on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research note on Thursday, October 24th. Redburn Atlantic cut shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a research note on Tuesday, October 8th. Finally, Morgan Stanley lifted their target price on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 in the last three months. Company insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

Hedge funds and other institutional investors have recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC lifted its position in CME Group by 21.2% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after acquiring an additional 8,443 shares during the last quarter. Duality Advisers LP acquired a new position in CME Group during the 1st quarter valued at approximately $1,455,000. SG Americas Securities LLC increased its stake in CME Group by 312.2% during the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after purchasing an additional 42,996 shares in the last quarter. Cetera Investment Advisers increased its stake in CME Group by 429.1% during the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after purchasing an additional 38,540 shares in the last quarter. Finally, Brookstone Capital Management increased its stake in CME Group by 12.2% during the 2nd quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock valued at $6,156,000 after purchasing an additional 3,325 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 0.2 %

NASDAQ:CME opened at $223.08 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a market cap of $80.33 billion, a PE ratio of 23.46, a price-to-earnings-growth ratio of 5.67 and a beta of 0.55. The company has a 50 day simple moving average of $220.98 and a two-hundred day simple moving average of $209.58.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the company posted $2.25 EPS. Research analysts forecast that CME Group will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.06%. CME Group’s dividend payout ratio (DPR) is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.